Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second‐line therapy for patients with advanced pancreatic cancer
Year: 2008
Type: article
Study design: Clinical Trial
Source: Cancer
DOI: 10.1002/cncr.23810
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2027814079
